1Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm [J]. Neurosurgery, 2000, 46(3): 517～530.?A
2Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage [J]. Pharmacology, 2002, 88(3): 227～249.?A
3Kwan AL, Lin CL, Chang CZ, et al . Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits [J]. Clin Sci (Lond), 2002, 10348 (Suppl): 414S～417S.?A
4Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration [J]. Net Rev Neurosci, 2001, 2(10): 734～744.?A
5Fassbender K, Hodapp B, Rossol S, et al . Inflammatory cytokines in subarachnoid hemorrhage: association with abnormal blood flow velocities in basal cerebral arteries [J].J Neurol Neurosurg Psychiat 2001, 70(4): 534～537.?A
6Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ishemic deficits in patients with aneurismal subarachnoid hemorrhage [J]. Korean Med Sci, 2001, 16(6): 774～780.?A
7Takizawa T, Tada T, Kitazawa K, et al . Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage [J]. Neurol Res, 2001, 23(7):724～730.?A
8Juvela S. Plasma endothelin concentrations after aneurismal subarachnoid hemorrhage [J]. Neurosurgery, 2000, 92(3):390～400.?A
9Aihara Y, Kasuya H, Onda H, et al. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage [J]. Stroke, 2001,32(1): 212～217.?A
10Thai QA, Oshiro EM, Tamargo R J, et al . Inhibition of experimental vasospasm in rats with the periadventitial administration of ibupeofen using controlled-release polymers [J].Stroke, 1999, 30(1): 140～147.?A
